Repros Therapeutics Inc
(NASDAQ: RPRX)
+0.32
+2.06%
Repros Therapeutics Inc, a small-cap unknown style company in the health care sector, is expected to significantly underperform the market over the next six months with very high risk.
10 is the best possible rating.
Shares are under heavy accumulation by financial institutions. Positive for a small company like RPRX
ConThe most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
The price-to-earnings multiple is a negative number. No effect
One or more analysts has modestly decreased quarterly earnings estimates for RPRX. Negative
The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
One or more analysts has modestly decreased quarterly earnings estimates for RPRX. Negative
Insider trading information is unavailable or inconsistent.
Shares are under heavy accumulation by financial institutions. Positive for a small company like RPRX
The price-to-earnings multiple is a negative number. No effect
Price-to-sales information is unavailable or inconsistent.
The ratio of RPRX's price-to-earnings multiple to its five-year growth rate is unavailable or inconsistent.
The StockScouter measure of relative price change and consistency is flat. Neutral
Previous day's closing price for RPRX was close to its 50-day moving average. Neutral
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 5/23/2013 8:05 PM ET
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
